Bassam Damaj

A visionary entrepreneur and stalwart in the global healthcare domain, Dr. Bassam Damaj's raison d'être lies in sculpting innovative healthcare enterprises. With a career spanning over twenty years, Dr. Damaj has solidified his reputation in the biotechnology and pharmaceutical sectors, navigating both research and commercial landscapes with well-being.

His entrepreneurial journey is punctuated by the foundation of seven trailblazing companies. Of these, three made their illustrious debut on NASDAQ, underscoring his prowess in steering startups to esteemed heights. His acumen in forging commercial collaborations is evident, with over $1 billion in partnerships with titans in the pharmaceutical and biotech arena. With a proven track record in capital mobilization, Dr. Damaj has successfully orchestrated fundraising campaigns in the US and Europe, amassing over $500 million for his ventures.

Dr. Damaj's expertise spans a comprehensive spectrum: from startup incubation, drug development, and market penetration to strategic planning, clinical operations, and investor relations. His international endeavors encompass markets such as Europe, Canada, the US, and MENA regions. He's also a virtuoso in M&A, with notable involvements in regions like US, Canada, France, Spain, and Denmark, to name a few.

His specialties are a testament to his diverse skill set: encompassing biotechnology, life sciences, biopharmaceuticals, and pharmaceuticals. Adept in strategic planning, operations, and financial management, Dr. Damaj's proficiency extends to clinical development, regulatory strategy formulation, and market commercialization. His therapeutic expertise includes oncology, infectious and autoimmune diseases, medical devices, and OTC consumer healthcare. Additionally, he boasts a robust portfolio in direct-to-consumer sales and marketing across multiple platforms and regions.

In essence, Dr. Bassam Damaj, with his multifaceted experience, continues to be a torchbearer in the realm of healthcare entrepreneurship, setting benchmarks and redefining industry standards